CARLSMED, INC.
CARL
Get informed when a big investor buys or sells
+ FollowMarket Cap$273.75M
Close$
Share Statistics
| Market cap | $273.75 Million |
|---|---|
| Enterprise Value | $217.99 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.12 |
| Beta | 1.97 |
| Outstanding Shares | 26,835,841 |
Return
| Return on Equity | -35.97% |
|---|---|
| Return on Assets | -27.94% |
| Return on Invested Capital | -34.90% |
Valuation & Multiples
| P/E Ratio | -4.13 |
|---|---|
| PEG | -7.97 |
| Price to Sales | 4.92 |
| Price to Book Ratio | 3.28 |
| Enterprise Value to Revenue | 3.86 |
| Enterprise Value to EBIT | -5.73 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 6, 2026
EPS Estimate
$-0.38
Average shareholder expectationRevenue Estimate
$14.94 M
Average shareholder expectationNext Earnings Call
Expected Date
July 21, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
$18.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 37.28%▲ 15.11% |
|---|---|
| Total Invested | $48.00M▼ 16.83% |
| Investors Holding | 66▲ 9.00% |
ESG Score
No data
About CARLSMED, INC.
100 employees
CEO: Michael John Cordonnier Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product ...